Companies
Stay informed about the latest developments and news from cannabis companies with Business of Cannabis. Learn about new products, mergers and acquisitions, and more.
Companies · page 3
- M&A Activity
Curaleaf’s Aurora Bid Is a Fight for Europe’s Cannabis Crown
Curaleaf Holdings (CURA) announced this week that it intends to launch an unsolicited take-over bid of its rival Aurora Cannabis (ACB) in what would mark one of the most consequential consolidation moves in industry history.
- Business
Data is Becoming Cannabis’ Most Valuable Crop
For more than a decade now, the world’s largest retail conglomerates have been quietly building their consumer data empires.
- M&A Activity
Argent Biopharma’s CannEpil to Target $3bn Veterinary Pain Market, Weeks After Debt-Relief Deal
Argent Biopharma’s (RGT) flagship CannEpil cannabis drug is set to pivot into the veterinary market, just weeks after it signed away the commercial rights in exchange for debt relief.
- Interviews
Cannabis Opportunity ‘Greater Today’ Than in 2019, Says the Lender Who Has Committed $550m
Just over a month ago, one of the most interesting and potentially consequential hearings in the history of US cannabis policy began.
- Clinical Research
A Cannabis Flavonoid Stopped Up to 99% of Cancer-Cell Growth in Lab Tests
Standard Seed Corporation (SSC), a cutting edge AI botanical-research company, believes it has identified a compound native to cannabis which could inhibit the growth of cancer cells by over 90% in some of the most aggressive forms of cancer.
- CBD Market
CBD Brand Director Sentenced for Covid Loan Fraud and Money Laundering
The director of UK CBD brand Virtutum Limited, which traded as CBD Asylum in Hull, has been given a suspended prison sentence for fraud and money laundering.
- Clinical Research
Argent Trades Global Rights to Lead Cannabis Drug For Debt Relief in New $5.5m Deal
Argent BioPharma (RGT), formerly MGC Pharmaceuticals, has sold the global commercialisation rights of its leading epilepsy drug, CannEpil, in order to clear a sizable chunk of its debt.
- Prescribers & Clinics
Cantourage Bets on Own Brand to Defend Flower Margins
Cantourage Group SE has announced the launch of its first proprietary medical cannabis brand for the German market, in a meaningful pivot for the distributor.
- Pharmaceutical
Ananda Pharma Doses First Patient in NIHR-Backed CIPN Trial
Ananda Pharma has dosed the first patient in the ACTiON trial, a Phase 2 NIHR-funded study evaluating MRX1, the company’s proprietary CBD-based oral solution, as a treatment for chemotherapy-induced peripheral neuropathy (CIPN), a debilitating nerve-damage condition caused by chemotherapy for which no effective therapies currently exist.
- Medical Cannabis
Curaleaf Becomes First to Register Cannabis Preparations Under Spain’s New Medical Framework
Spain’s medicines regulator has officially approved the first two oil-based preparations as part of its recently approved national medical cannabis scheme.
- Pharmaceutical
World’s Largest CBD Insomnia Trial Could Hand Avecho an Australian Monopoly
The world’s largest clinical trial on cannabidiol (CBD) as a treatment for insomnia has been given the green light to complete its Phase III trial, transforming the fortunes of Avecho Biotechnology, and potentially the lives of insomnia sufferers worldwide.
- Press releases
Releaf Becomes First Ever B Corp Certified Medical Cannabis Company
Releaf, the UK’s leading medical cannabis clinic, has today announced it has become the first medical cannabis clinic to achieve B Corp certification.
